Skip to main content

What the FDA labels say about taking them together

Caffeine and deferasirox

Deferasirox's FDA label of January 28, 2026 names caffeine in its drug interactions section; the caffeine labels PlainMeds reads (2) do not name deferasirox. The deferasirox label: “Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate concentration when these drugs are coadministered.”

Check it at the source: the caffeine FDA label on DailyMed (effective July 29, 2026, Sagent Pharmaceuticals); the deferasirox FDA label on DailyMed (effective January 28, 2026, Novartis Pharmaceuticals Corporation).

What does the caffeine label say about deferasirox?

Caffeine's label (effective July 29, 2026) and its 1 other brand-application label do not name deferasirox in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (caffeine citrate), Sagent Pharmaceuticals, effective July 29, 2026 (SPL set 5f38c395-0093-4afd-89ec-f96e5dc0934a), via openFDA; the full label on DailyMed

What does the deferasirox label say about caffeine?

Deferasirox label, drug interactions

Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.

Source: FDA drug label (Exjade), Novartis Pharmaceuticals Corporation, effective January 28, 2026 (SPL set 3495a70c-870c-4968-940e-8baea152cf85), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

7Caffeine generic labelers
20Deferasirox generic labelers
CaffeineDeferasirox
Labeled forn/an/a
Boxed warningNoYes
Pharmacy cost (NADAC)$0.083 per tablet 200 mg tablet$1.25 per tablet 360 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?